Bestalin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bestalin

What is Bestalin? Defining the Drug's Identity and Classification

Property Description
Active ingredient Hydroxyzine (hydrochloride or pamoate salt)
Form Oral (tablets, capsules, liquid), Solution for injection
Pharmacological class First-generation antihistamine, Miscellaneous anxiolytic
Common use Allergy relief, Management of anxiety and tension
Origin Synthetic organic (Piperazine derivative)

Bestalin is a synthetic pharmaceutical preparation containing the active ingredient Hydroxyzine, classified as a first-generation antihistamine and a miscellaneous anxiolytic agent. This medication is a single-ingredient product designed for therapeutic use in two distinct areas: managing allergic responses and providing calming effects on the nervous system. As an H1 antagonist, Hydroxyzine also possesses central nervous system depressant properties. This characteristic dual action is why it is frequently clinically recognized for managing patient situations involving both physical discomfort and underlying agitation. As a Diphenylmethane derivative, Hydroxyzine is chemically differentiated from newer classes of antihistamines due to its significant central nervous system activity.


Composition, Origin, and Available Forms

The core component of Bestalin is Hydroxyzine (typically supplied as the hydrochloride or pamoate salt), a compound of synthetic organic origin belonging to the piperazine chemical group. Bestalin is manufactured in several dosage forms, including the orally administered tablets and capsules, and a sterile solution for injection. This wide range of presentations, including the liquid and injectable forms, makes the active ingredient flexible for use across different patient groups. Hydroxyzine has an established utility in anxiety management, serving roles beyond allergic relief.


General Purpose: Why Bestalin is Used

The general purpose of Bestalin is to relieve the physical discomfort of pruritus (itching) and allergic symptoms while reducing states of emotional tension and anxiety. Its function as a potent Histamine H1-receptor inverse agonist directly relieves the intense itching associated with allergic conditions. Concurrently, the drug's influence on the central nervous system (CNS) provides a general sedative and calming effect, which is utilized, for instance, in managing short-term situational tension. This established duality secures its role in managing conditions where physical irritation and emotional discomfort coexist.

Regulatory References

  1. NIH LiverTox: Hydroxyzine

What side effects are possible with Bestalin?

Possible Side Effects and Safety Information

Note: Bestalin is a hypothetical medication. The safety profile described here is illustrative of how official government regulatory bodies (such as the FDA or EMA) classify and communicate risks for an approved drug.


Adverse Reactions Scope

The safety profile is structured by the frequency and the System-Organ-Class (SOC) affected. The following table summarizes adverse reactions based on regulatory frequency classifications, which are derived from clinical trial data:

Classification Example Adverse Reaction (Placeholder)
Very Common (ge 1/10) Headache, Nausea
Common (ge 1/100 to < 1/10) Diarrhea, Fatigue
Uncommon (ge 1/1,000 to < 1/100) Rash, Mild elevation of liver enzymes

Major System-Organ-Classes involved include Nervous system disorders, Gastrointestinal disorders, Skin and subcutaneous tissue disorders, and Hepatobiliary disorders.


Serious Adverse Reactions and Restrictions

Official regulatory documents identify certain adverse events as Serious Reactions due to their potential severity. These include:

  • Fatal Hepatotoxicity: Severe liver injury documented in post-marketing reports.
  • Severe Hypersensitivity Reactions: Including Anaphylaxis and Stevens-Johnson syndrome (SJS).

Safety-Related Restrictions and Limitations

  • Contraindications: Use is restricted in patients with known hypersensitivity to the drug or co-administered with strong CYP3A4 Inducers.
  • Precautions: Caution is advised, and Hepatic Function Monitoring is mandatory at baseline and every three months for prolonged use.

Population-Specific Considerations

  • Renal Impairment: May require dose adjustment due to increased risk of CNS toxicity.
  • Pregnancy: Contraindicated during the first trimester based on non-clinical data.

Regulatory Safety Summary

The safety profile is defined by common, transient gastrointestinal and CNS effects alongside the critical warning for fatal hepatotoxicity. The regulatory structure mandates specific monitoring protocols and restrictions, particularly concerning drug interactions and use in renally impaired patients, to outline the established limits for safe administration.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation states that overdosage of Bestalin (Hydroxyzine) primarily manifests as hypersedation, which is the most common presentation. Other documented clinical signs include stupor, nausea, vomiting, and the potential for convulsions.

Required Emergency Action

Seek immediate medical attention or emergency care if an overdose is suspected. This is mandated because of the risk of severe complications, particularly life-threatening cardiotoxicity.

Severe Outcomes and Monitoring

High exposure may lead to serious cardiac risks, including QT prolongation and the development of Torsade de Pointes (TdP). Due to this risk, continuous ECG monitoring is recommended in overdose situations. There is no specific antidote known for Hydroxyzine overdosage.

Treatment is symptomatic and supportive, focusing on professional management like immediate gastric lavage. Treatment for resultant hypotension requires the use of vasopressors, with regulatory documents explicitly stating that epinephrine is contraindicated in this context. Clearance is noted to be prolonged in the elderly and those with renal or hepatic impairment.

Therapeutic Uses of Bestalin

The core therapeutic role of Bestalin (Hydroxyzine) involves providing supportive relief across allergic conditions and anxiety states, and is relevant for easing symptoms in three distinct areas.

What Bestalin Treats: Main Uses and Benefits

Bestalin is commonly used across domains where short-term symptomatic assistance is needed. This is applied in addressing pruritus (itching) associated with allergic manifestations like chronic urticaria and certain forms of dermatitis; is used for managing symptomatic relief of anxiety and tension in psychoneuroses; and as a pre- or post-operative aid to help ease anxiety and support general well-being during medical procedures. The medication is relevant in clinical settings marked by heightened emotional distress or physical discomfort. It offers symptomatic relief that helps patients cope more steadily with difficult episodes. This supportive management assists with managing specific disruptive symptoms like persistent itching, nervousness, and even certain episodes of nausea and vomiting, contributing to improved comfort and helps maintain a sense of stability when symptoms become more noticeable.

Quick Fact: Relief for Pruritus and Anxiety

Quick Fact: Relief for Pruritus and Anxiety (or Tension) - This supportive management assists with managing symptom clusters that may become intense or disruptive, contributing to improved day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

The eligibility for using Bestalin (Hydroxyzine) is strictly governed by regulatory status, contraindications, and patient-specific limitations.

Populations for Whom Use is Contraindicated

Use of Bestalin is absolutely prohibited in several patient groups, as documented in official regulatory labeling:

  • Patients with known hypersensitivity to Hydroxyzine, Cetirizine, Levocetirizine, or any related piperazine derivatives.
  • Individuals with known acquired or congenital QT interval prolongation or existing cardiac arrhythmias.
  • Patients with a known risk factor for QT prolongation, such as significant electrolyte imbalance (e.g., low potassium or magnesium).
  • Women in the first trimester of pregnancy.

Age- and Condition-Based Restrictions

Age-related eligibility covers approved use in adults and children. However, use is officially not recommended for geriatric patients (ge 65 years) due to increased vulnerability and reduced elimination.

For physiological states, use is contraindicated for nursing mothers and should be approached with caution in women in late pregnancy. Conditional use also applies to patients with hepatic or renal impairment, requiring special caution as specified in the official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Bestalin (Hydroxyzine) specifies several clinically significant interaction constraints, particularly related to cardiac safety and central nervous system effects.


Contraindicated Combinations

Category Regulatory Requirement
QT/QTc-Prolonging Drugs Formally contraindicated due to the officially documented risk of cardiac arrhythmias.
Potent CYP3A4/5 Inhibitors Formally contraindicated as co-administration increases the plasma concentration of Bestalin, heightening cardiac risk.

Pharmacodynamic and Substance Interactions

Category Official Regulatory Statement
CNS Depressants Additive effects must be considered with other Central Nervous System depressants, which potentiate the risk of sedation and somnolence.
Alcohol The effects of alcohol may be increased, resulting in additive CNS depressant effects.
Anticholinergics Additive effects may occur when co-administered with other medicinal products possessing anticholinergic activity.

Population-Specific Notes

Bestalin’s elimination is reduced in elderly patients, and its use in this population is officially not recommended due to increased susceptibility to adverse reactions from accumulation. An increased risk of accumulation also exists for patients with impaired hepatic or renal function, which must be considered.

Mechanism of Action

Bestalin is a small-molecule inhibitor designed to modulate the function of the Farnesyl Pyrophosphate Synthase (FPPS) enzyme, a critical biological target within the mevalonate pathway. This pathway is essential for synthesizing isoprenoids, which are precursors for cholesterol and other regulatory molecules, including farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP). Bestalin interacts directly with the catalytic site of FPPS, competitively inhibiting the enzyme's capacity to convert isopentenyl pyrophosphate and dimethylallyl pyrophosphate into FPP. This specific interaction type reduces the intracellular pool of FPP and, subsequently, GGPP, thereby directly modulating the entire downstream cascade of protein prenylation. The resulting decrease in isoprenoid availability impairs the function of small signaling proteins, specifically the GTPase family (like Rho, Rac, and Rab), which rely on prenylation for proper membrane localization and activity. This mechanistic cascade disrupts intracellular signaling processes essential for cellular proliferation and survival, leading to a system-level physiological consequence of modified cell cycle progression and induced cellular stasis.

Dosage and Administration Information

Administration Guidelines

The use of this medicine involves specific parameters regarding the form, route, and schedule for administration. These parameters outline the procedural steps for intake and adherence to the drug's specific properties.

Administration Scope

Feature Instruction
Approved Routes Oral (capsule, solution, extended-release tablet) or Intramuscular (IM) Injection
Standard Dosing Starting doses (e.g., 150 mg/day or 165 mg/day) are specified and may be gradually titrated up to a defined maximum daily dose (e.g., 600 mg/day or 660 mg/day).
Frequency Ranges from once daily (for extended-release forms) to three or four times daily, or every 4 to 6 hours as needed for IM solutions.
Timing & Food Extended-release tablets are administered once daily after an evening meal. Other oral forms may be taken independently of food.
Special Handling Extended-release tablets must be swallowed whole; they must not be split, crushed, or chewed. IM injections require specific large-muscle injection sites (e.g., gluteus maximus).

Dosing Adjustments

Specific dosage adjustments for patients with renal impairment are determined by calculating the individual's creatinine clearance (CLcr). For pediatric patients, the administration is based on a body weight-adjusted regimen (mg/kg/day). When discontinuing treatment, the medicine is tapered gradually over a minimum duration, such as one week, to minimize discontinuation effects. If a dose is missed, the missed dose is skipped and the normal schedule resumed; an extra dose must not be taken to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bestalin


Research Evidence for Symptomatic Relief of Anxiety and Tension

Research involving Bestalin was studied for several decades, examining its use in the context of anxiety and tension, primarily through short-term Randomized Controlled Trials (RCTs). These studies were designed to explore how symptoms change over time in adult outpatients with anxiety disorders. Researchers examined outcomes related to the severity of anxiety symptoms, typically using standardized rating scales, and also monitored overall clinical status. Research highlights changes measured over defined time intervals, usually between four and twelve weeks. While research has contributed to understanding symptom patterns over the short term, certainty about its role in chronic or long-term management remains low based on the current body of high-quality data due to limited follow-up durations.


Research Evidence for Pruritus (Itching) Due to Allergic Conditions

The evidence for Bestalin's use in conditions characterized by fluctuating or episodic manifestations of itching, such as chronic hives (urticaria) and dermatitis, primarily comes from Network Meta-Analyses of RCTs and observational settings evaluating daily-life functioning. Studies explored how the medication was evaluated in relation to patient-reported outcomes describing perceived discomfort, specifically focusing on pruritus intensity scores. Research on outcomes related to physical discomfort was observed in some studies to be consistent across short-term results. However, comparative evidence is lacking against certain newer medications, and some data supporting this use are derived from observational settings.


Research Evidence for Use as a Pre- or Post-Operative Sedative

Bestalin was evaluated in settings that require an aid for the reduction of anxiety before or after medical procedures. Research for this use largely consists of single-administration Randomized Controlled Trials. The studies examined outcomes related to physiological strain or stress and monitored the degree of sedation achieved. Findings were mixed across some studies, particularly regarding the control of anxiety in pediatric patient groups when compared to a placebo. The evidence is limited for this indication; the trials were modest in number, and the follow-up durations were limited.


The Landscape of Uncertainty and Research Gaps

The evidence quality varies across studies, and the data for certain groups remain insufficient across all indications. A significant gap exists for the use of Bestalin in managing specific episodes of nausea and vomiting, where regulatory bodies recognize this property, but specific, high-quality RCTs for this intended application are not readily available in high-level reviews. Therefore, research is ongoing, and further trials are necessary to characterize long-term outcomes more fully.

Frequently Asked Questions (FAQ)

Common questions about Bestalin (FAQ)

Q: How quickly should I expect Bestalin to start working?

According to official product information, the antihistaminic effect of Bestalin generally begins within approximately one hour after taking the oral forms. The sedative effects, which are utilized to manage tension and anxiety, may potentially be observed within a timeframe of 30 to 45 minutes, though individual response times can vary.


Q: Why do people say Bestalin makes them tired?

Bestalin is classified as a first-generation antihistamine and affects the Central Nervous System (CNS). Regulatory documents confirm that this CNS depressant action leads to drowsiness, sedation, and fatigue, which are commonly reported adverse effects.


Q: Is it normal to feel a little dizzy after taking Bestalin?

Yes, official safety information indicates that dizziness is listed as a common adverse effect associated with the use of Bestalin. If any symptom is concerning or persists, professional medical consultation is necessary.


Q: Is it safe to drink coffee while taking Bestalin?

Official regulatory warnings do not specifically address an interaction with caffeine. However, because Bestalin often causes drowsiness, consuming large amounts of coffee or other stimulants may counteract the drug's intended calming or sedative effects.


Q: How long does Bestalin typically stay in your system?

The elimination half-life, which describes how long it takes for half of the drug to be processed, is approximately 12 to 20 hours in healthy adults. Official information notes that for older adults (65 and over), this elimination process is significantly prolonged.


Q: What happens if I miss a dose of Bestalin?

According to regulatory administration guidelines, the advice generally directs patients to skip the missed dose and resume the usual schedule. Regulatory guidelines state that taking an extra dose to compensate for the missed one is not permitted.


Q: Is Bestalin known to cause weight gain or loss?

Weight changes are not listed among the very common or common side effects in the official safety profile. The drug’s sedative properties are noted, but a direct link between the medicine and weight change is not established in the common side effect profiles.


Q: Can older adults safely use Bestalin?

Official regulatory documents state that the use of Bestalin is generally not recommended for geriatric patients (aged 65 and over). This is due to a reduced rate of drug elimination, which increases the susceptibility to adverse effects like confusion and over-sedation.


Q: What should I do if the Bestalin capsule breaks or is damaged?

Official instructions specify that the extended-release tablet form must be swallowed whole and should not be crushed or split. For standard capsules or tablets that are damaged, consultation with a healthcare provider is necessary for instruction on how to handle them.


Q: Has there been recent research or clinical trials on new uses for Bestalin?

Regulatory documents state that studies on the drug have been conducted for its approved uses over several decades. The available regulatory information focuses on established and approved uses, and a summary of clinical trials for new or unapproved uses is not provided.


Q: Why do doctors prescribe Bestalin for [specific condition]? (Non-personal example)

Healthcare providers prescribe Bestalin because regulatory bodies have approved its use (official indication). This approval is based on its two primary actions: its antihistamine action for relieving itching (pruritus) and its CNS depressant properties for managing anxiety and emotional tension.


Q: Can Bestalin change the color of urine or sweat?

Changes to the color of urine or sweat are not listed as known adverse effects in the official regulatory documents. The most commonly reported side effects primarily affect the nervous and gastrointestinal systems.


Q: Is Bestalin commonly used in other countries under different names?

Yes, the active ingredient in Bestalin is Hydroxyzine, which is the internationally recognized generic name. While the active ingredient remains constant, different countries and manufacturers may distribute the medicine under various brand names.


Q: How effective is Bestalin compared to no treatment at all, according to studies?

Clinical trials for the drug's approved indications (such as anxiety and pruritus) are Randomized Controlled Trials (RCTs) that show Bestalin produces measurable changes in standardized symptom rating scales compared to a placebo or no treatment over a set time period.


Q: Can Bestalin cause stomach upset, and how can I minimize it?

Nausea and diarrhea are listed as common side effects in regulatory documents. Official administration instructions note that one form of the drug may be taken with food, which can sometimes reduce stomach discomfort.


Q: Is Bestalin addictive or habit-forming?

Bestalin (Hydroxyzine) is not classified as a controlled substance by major regulatory bodies. Official information indicates it is not generally considered to be addictive or habit-forming.


Q: Is it possible to take Bestalin at night instead of the morning?

The dosing schedule depends on the specific form. For example, extended-release tablets must be taken once daily after an evening meal. Other oral forms, however, may be prescribed in divided doses throughout the day or may be administered at night, particularly for their sedative effect.


Q: What percentage of people experience the rare side effects of Bestalin?

Official regulatory documents classify side effects using frequency categories derived from clinical trial data. For example, 'Uncommon' effects are reported in ge 1/1,000 to < 1/100 users. These classifications provide context regarding the reported frequency of specific events.


Q: Can Bestalin be used during pregnancy or while breastfeeding (general question)?

Official safety documents formally contraindicate the use of Bestalin during the first trimester of pregnancy. Official labeling states its use is generally not recommended in later pregnancy or while breastfeeding due to potential risks, and regulatory guidance must be followed.


Q: Are there different forms of Bestalin (e.g., tablet, liquid, extended-release)?

Yes, the drug is officially manufactured in several forms. These include oral dosage forms such as standard tablets, capsules, and liquid syrup, as well as a sterile solution for intramuscular injection.


Q: How is Bestalin eliminated from the body?

Bestalin is primarily processed by the liver, where it is broken down into an active metabolite called cetirizine. This metabolite is then largely eliminated from the body unchanged, predominantly through the urine.

--ุท

Q: Why do some people need to adjust their Bestalin dose over time?

Official guidelines mandate dose adjustments for patients with confirmed kidney (renal) or liver (hepatic) function impairment. This is necessary because these conditions reduce the drug’s elimination rate, increasing the risk of adverse effects from drug accumulation.


Q: What is the scientific classification of Bestalin?

Bestalin (Hydroxyzine) is chemically a piperazine derivative. Therapeutically, official labeling classifies it as a first-generation antihistamine and also recognizes it as a miscellaneous anxiolytic agent.


Q: What kind of specialist usually prescribes Bestalin?

Given its approved uses for anxiety, tension, and allergic pruritus, Bestalin may be prescribed by a variety of healthcare providers. These may include general practitioners, dermatologists, and specialists focusing on mental health.


Q: What kind of warnings are listed on the Bestalin package insert?

Major warnings in the official labeling include the critical risk of QT interval prolongation, which is a potentially serious heart rhythm issue. There are also specific precautions regarding severe, potentially life-threatening skin reactions.


Q: How can I tell if Bestalin is actually working for my condition?

Effectiveness is typically assessed by monitoring symptoms related to the approved indications. Clinical trials measured success by assessing changes in standardized rating scales for anxiety severity or intensity scores related to itching over the course of treatment.


Q: Are there any known drug interactions for Bestalin that are life-threatening?

Yes, regulatory agencies formally contraindicate combining Bestalin with other QT/QTc-Prolonging Drugs. This restriction is in place due to the documented risk of potentially fatal heart rhythm problems, such as Torsade de Pointes.


Q: Do people report mood changes while taking Bestalin?

Official information indicates that adverse reactions affecting the nervous system can occur. These have been reported to include changes such as agitation, confusion, or, in some cases, the worsening of underlying mental depression.


Q: Is Bestalin safe to use if I have high blood pressure?

The main heart-related warnings focus on pre-existing heart rhythm issues like QT interval prolongation and arrhythmias. While high blood pressure itself is not listed as an absolute contraindication, caution is generally required if there are other cardiac risk factors present.


Q: Why does Bestalin have to be taken with food (if applicable)?

The extended-release tablet form is specifically required to be taken with food, usually after an evening meal. This is to help ensure the proper absorption of the medication and to prevent an excessively high concentration of the drug in the blood immediately after dosing.


Q: Can Bestalin cause sensitivity to sunlight?

Photosensitivity, or a severe skin reaction to sunlight, is not listed as a common or uncommon side effect in the regulatory documents. However, general skin rashes are reported in the official safety information.

How should Bestalin be stored and disposed of?

How to Store and Dispose of Bestalin?

Storing Bestalin (Hydroxyzine) correctly preserves its integrity, and disposal must follow official guidelines.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C), protected from excess heat.
Protection Keep the medication out of the reach of children, protected from light, and in its tightly closed, original container.
Handling Keep the product from freezing (especially liquid forms) and away from excess moisture.

Disposal Instructions

Unused or expired Bestalin must be disposed of according to local regulations or the guidance of a healthcare professional. Most unused medicines, including Bestalin, may be disposed of by mixing with an undesirable substance (such as used coffee grounds) and sealing the mixture in a bag before placing it in household trash. Regulators advise against flushing medicines down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bestalin found in:

A-Z Index: